198 related articles for article (PubMed ID: 3498561)
1. Basal and stimulated release of calcitonin gene-related peptide (CGRP) in patients with medullary thyroid carcinoma.
Mason RT; Shulkes A; Zajac JD; Fletcher AE; Hardy KJ; Martin TJ
Clin Endocrinol (Oxf); 1986 Dec; 25(6):675-85. PubMed ID: 3498561
[TBL] [Abstract][Full Text] [Related]
2. [Radioimmunoassay of the calcitonin gene-related peptide and its measurement in the plasma of patients with medullary thyroid carcinoma and in the cerebrospinal fluid of normal subjects].
Kim S; Morimoto S; Fukuo K; Hironaka T; Koh E; Shiraishi T; Onishi T; Kumahara Y; Kawai Y; Shiotani Y
Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):884-93. PubMed ID: 3500074
[TBL] [Abstract][Full Text] [Related]
3. Determination of plasma calcitonin gene-related peptide concentrations by a new immunochemiluminometric assay in normal persons and patients with medullary thyroid carcinoma and other neuroendocrine tumors.
Carter WB; Taylor RL; Kao PC; Heath H
J Clin Endocrinol Metab; 1991 Feb; 72(2):327-35. PubMed ID: 1991803
[TBL] [Abstract][Full Text] [Related]
4. [Radioimmunoassay of plasma calcitonin gene-related peptide (CGRP) levels in patients with endocrine tumor].
Takami H; Shikata J; Horie H; Horiuchi J; Sakurai H; Ito K
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2219-25. PubMed ID: 2786708
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma.
Månsson B; Ahrén B; Nobin A; Böttcher G; Sundler F
Surgery; 1990 Feb; 107(2):182-6. PubMed ID: 2300897
[TBL] [Abstract][Full Text] [Related]
6. Elevated plasma calcitonin gene-related peptide and the symptoms associated with medullary thyroid cancer.
Rubinstein C; Fletcher DR; Shulkes A; Hardy KJ
Aust N Z J Surg; 1992 Nov; 62(11):892-6. PubMed ID: 20169709
[TBL] [Abstract][Full Text] [Related]
7. CGRP radioreceptor assay: a new diagnostic tool for medullary thyroid carcinoma.
Wimalawansa SJ
J Bone Miner Res; 1993 Apr; 8(4):467-73. PubMed ID: 8475796
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of calcitonin gene-related peptide (CGRP) in a rat medullary thyroid carcinoma cell line.
Schifter S; Johansen TE; Johnsen AH
Peptides; 1995; 16(8):1489-96. PubMed ID: 8745063
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin gene-related peptide and calcitonin as tumour markers in MEN 2 family screening.
Schifter S
Clin Endocrinol (Oxf); 1989 Mar; 30(3):263-70. PubMed ID: 2574082
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin gene-related peptide: possible tumor marker for medullary thyroid cancer.
Poston GJ; Seitz PK; Townsend CM; Alexander RW; Rajaraman S; Cooper CW; Thompson JC
Surgery; 1987 Dec; 102(6):1049-54. PubMed ID: 3500524
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of calcitonin gene-related peptide in patients with medullary thyroid carcinoma.
Kim S; Morimoto S; Kawai Y; Koh E; Onishi T; Ogihara T
J Clin Chem Clin Biochem; 1989 Jul; 27(7):423-7. PubMed ID: 2794874
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin gene-related peptide and calcitonin in medullary thyroid carcinoma.
Schifter S; Williams ED; Craig RK; Hansen HH
Clin Endocrinol (Oxf); 1986 Dec; 25(6):703-10. PubMed ID: 3308183
[TBL] [Abstract][Full Text] [Related]
13. [Measurement of plasma calcitonin gene-related peptide (CGRP) level in patients with thyroid disease].
Takami H; Shikata J; Ozaki O; Mimura T; Ito K
Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):401-6. PubMed ID: 2359396
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin gene-related peptide as a tumor marker for medullary thyroid carcinoma.
Takami H; Ito K
Int Surg; 1992; 77(3):181-5. PubMed ID: 1399365
[TBL] [Abstract][Full Text] [Related]
15. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
[TBL] [Abstract][Full Text] [Related]
16. Effects of in vivo stimulation on molecular forms of circulatory calcitonin and calcitonin gene-related peptide in man.
Wimalawansa SJ
Mol Cell Endocrinol; 1990 May; 71(1):13-9. PubMed ID: 2365132
[TBL] [Abstract][Full Text] [Related]
17. Role of cytosolic free calcium concentration in the secretion of calcitonin gene-related peptide and calcitonin from medullary thyroid carcinoma cells.
Haller-Brem S; Muff R; Petermann JB; Born W; Roos BA; Fischer JA
Endocrinology; 1987 Oct; 121(4):1272-7. PubMed ID: 3498624
[TBL] [Abstract][Full Text] [Related]
18. Determination of silica-purified plasma calcitonin for the detection and management of medullary thyroid carcinoma: comparison of two provocative tests.
Gharib H; Kao PC; Heath H
Mayo Clin Proc; 1987 May; 62(5):373-8. PubMed ID: 3573825
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin release from medullary thyroid carcinoma by thyrotropin-releasing hormone: comparison with calcium injection.
Oishi S; Yamauchi J; Fujimoto Y; Hamasaki S; Umeda T; Sato T
Acta Endocrinol (Copenh); 1992 Apr; 126(4):325-8. PubMed ID: 1595326
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunoassay of calcitonin in plasma, normal thyroid, and medullary thyroid carcinoma of the rat.
Roos BA; Deftos LJ; Roberts G; Wilson P; Bundy L
J Lab Clin Med; 1976 Aug; 88(2):173-82. PubMed ID: 822106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
